In summary, HuR may emerge as a pivotal player in the regulation of tumor immune microenvironment across various cancer types, evidenced by its robust correlation with immune cells, tumor immune cell infiltration, and immune-related genes. This evidence concerns the gene ELAVL1 and cancer.